Delivery Order SPE2DB24D8001-SPE2DB25FLABJ
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $8.8K to Dakota Drug, Inc., a self-certified small disadvantaged business headquartered in Anoka, Minnesota, for the supply of Entresto 24 mg-26 mg tablets (60-count). The contract, which closed on August 14, 2025, operates under a firm fixed price structure with no set-aside designation. Dakota Drug, Inc. is fulfilling this requirement through its larger Indefinite Delivery Contract (SPE2DB24D8001) with DLA Troop Support...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The $6,816.41 firm fixed-price contract is for the delivery of ENTRESTO 24 MG-26 MG TABLET 60S, a pharmaceutical product. The contract has an ultimate completion date of March 17, 2025. Dakota Drug, Inc. is a key supplier for the DLA's Troop Support Medical division, providing a wide range of pharmaceutical and medical products to support U.S. Armed...
- The U.S. Defense Logistics Agency (DLA) awarded a $2,206.74 firm fixed-price delivery order contract to Dakota Drug, Inc., a self-certified small disadvantaged business operating as a for-profit subchapter S corporation. The contract is for the delivery of 60 tablets of the prescription medication Entresto (24 mg-26 mg) to support U.S. Armed Forces medical operations. This award is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by Dakota Drug, Inc. under the DLA Troop...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business located in Anoka, Minnesota. The contract is for the delivery of pharmaceutical products, specifically the medication Entresto 24 mg-26 mg tablets in 60-count bottles. The contract has a total ceiling value of $2,701.93 and a completion date of July 2, 2025. The contract is a firm-fixed price delivery order, and it is not set aside for any...
- This is a firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business, for the delivery of ENTRESTO 24 MG-26 MG TABLET 60S. The ceiling value of this contract is $2,910.31, with an ultimate completion date of October 21, 2024. Dakota Drug, Inc. is a key supplier of pharmaceutical products, medical supplies, and healthcare equipment to the U.S. federal government, particularly the Department of Defense. The...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, valued at $4,706.21, is for the delivery of ENTRESTO 97 MG-103 MG tablets in 60-count packages. The contract is a firm-fixed-price delivery order with a completion date of March 27, 2025. Dakota Drug, Inc. is a key supplier of pharmaceutical products, medical supplies, and healthcare equipment to the U.S. Department of Defense. The...
- This federal contract award, valued at $14,527.64, was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business, for the delivery of ENTRESTO 49 MG-51 MG TABLET 60S. The contract is a firm-fixed-price delivery order with a period of performance through October 29, 2024. Dakota Drug, Inc. is a key supplier to the DLA, holding a significant single-award Indefinite Delivery Contract (IDC) valued at $999,999,999.00 as part of the DLA Troop...
- This federal contract award, valued at $15,447.18, was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business located in Anoka, Minnesota. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) with the DLA, identified as SPE2DB24D8001, valued at $999,999,999.00. This IDC is part of the DLA Troop Support Medical's ECAT Generation V Program and covers the delivery of a wide range of pharmaceutical products,...
- The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order contract, SPE2DX15D8002|SPE2DX24F2TG3, to Dakota Drug, Inc., a self-certified small disadvantaged business, for the delivery of 60 tablets of the drug Entresto (24 mg-26 mg). The contract has a ceiling value of $5,926.14 and a period of performance ending on October 16, 2023. This award is part of the DLA Troop Support Medical's ECAT Generation V Program, a broader Indefinite Delivery Contract (IDC) with a...
- Dakota Drug, Inc., a self-certified small disadvantaged business operating as a for-profit subchapter S corporation, has been awarded a firm fixed price delivery order valued at $4,595.51 by the Defense Logistics Agency Troop Support Medical (DLA Troop Support Medical). Under this order, Dakota Drug will provide 60 tablets of Entresto 97 mg-103 mg to support DLA Troop Support Medical supply chain operations and maintain stock levels at military treatment facilities, including locations in Anoka,...
- SPE2DB24D8001Indefinite Delivery Contract
- SPE2DB24D8001-SPE2DB25FLABJDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $3,568.13 to Dakota Drug, Inc., a self-certified small disadvantaged business based in Anoka, Minnesota, for the supply of Entresto 24 mg-26 mg tablets (60-count units). The contract is structured as a firm fixed price delivery order with an ultimate completion date of July 23, 2025, and was awarded on July 22, 2025. This award carries no set-aside designation, reflecting an unrestricted competitive procurement process. The delivery order falls under Dakota Drug's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical's ECAT Generation V Program, valued at $999,999,999.00 and extending through December 31, 2025. Dakota Drug, Inc. has established itself as a critical pharmaceutical and medical supplies vendor to the Defense Logistics Agency, with a demonstrated capability to supply a comprehensive range of medications supporting U.S. Armed Forces medical operations. The company's federal contract portfolio includes cardiovascular medications, diabetes management products, respiratory treatments, and vaccines, among other pharmaceutical items. This delivery order for Entresto, a cardiovascular medication, represents one of numerous delivery orders the company fulfills under its master IDC with the Defense Logistics Agency, enabling efficient distribution of critical medical supplies to defense healthcare facilities across the military medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.6k | 7/22/25 |